Clinical Trials Directory

Trials / Completed

CompletedNCT06649578

Comparing Bariatric Surgery Outcomes in Predominantly High-Risk Asian Patients to Global Benchmarks

Comparing Bariatric Surgery Outcomes in Predominantly High-Risk Asian Patients to Global Benchmarks: Insights From a Decade-Long Cohort Study of 1016 Patients

Status
Completed
Phase
Study type
Observational
Enrollment
1,016 (actual)
Sponsor
National University Hospital, Singapore · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

While metabolic-bariatric surgery is a safe and well-established surgery, complications do occur and can have significant impact on the patient. With the study, the investigators aim to establish the proportion of patients that will have complications and understand what the impact of complications are on costs.

Detailed description

Complications after metabolic-bariatric surgery can be catastrophic and have significant impact on costs, morbidity, and mortality. As current global benchmarks for complications rates in MBS are based on standard risk patients in western populations, the benchmark complication rates in high-risk patients and Asian populations are unknown. The investigators aim to evaluate the incidence of complications in 1016 consecutive patients and the impact of complications on costs.

Conditions

Interventions

TypeNameDescription
PROCEDUREMetabolic-bariatric surgeryOur study is conducted in a predominantly high-risk Asian population that will be undergoing metabolic-bariatric surgery. The types of surgery can be divided into Laparoscopic Sleeve Gastrectomy (LSG), Roux-en-Y Gastric Bypass (RYGB) or One-Anastomosis Gastric Bypass (OAGB).

Timeline

Start date
2010-01-01
Primary completion
2023-02-01
Completion
2023-04-01
First posted
2024-10-21
Last updated
2024-10-23

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT06649578. Inclusion in this directory is not an endorsement.